Chargement en cours...
Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients
BACKGROUND. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AlphaMed Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3639527/ https://ncbi.nlm.nih.gov/pubmed/23576485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0351 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|